Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors.

Wagner LM, Crews KR, Iacono LC, Houghton PJ, Fuller CE, McCarville MB, Goldsby RE, Albritton K, Stewart CF, Santana VM